Nasal Decolonisation of MRSA
AbstractThe recent demonstration for the first time of urinary monic acid A as a clinical urinary biomarker of exposure to intra-nasal mupirocin during medication for methicillin-resistant Staphylococcus aureus (MRSA) offers a way of verifying adherence to the regimen. However, absence of the biomarker in some patients needs explanation, to ensure that efficient decolonisation has not been compromised by confounding circumstances, and that additional resistance to mupirocin has not unwittingly been encouraged. View Full-Text
Share & Cite This Article
Mantle, P. Nasal Decolonisation of MRSA. Antibiotics 2019, 8, 14.
Mantle P. Nasal Decolonisation of MRSA. Antibiotics. 2019; 8(1):14.Chicago/Turabian Style
Mantle, Peter. 2019. "Nasal Decolonisation of MRSA." Antibiotics 8, no. 1: 14.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.